Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Reaches New 12-Month High – Here’s What Happened

Shionogi & Co., Ltd. (OTCMKTS:SGIOY)’s share price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $8.29 and last traded at $7.96, with a volume of 150683 shares changing hands. The stock had previously closed at $7.78.

Shionogi & Co., Ltd. Trading Up 2.3 %

The company has a current ratio of 7.64, a quick ratio of 7.01 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $13.54 billion, a price-to-earnings ratio of 13.11, a P/E/G ratio of 2.37 and a beta of 0.21. The firm’s 50-day moving average is $7.51 and its 200 day moving average is $7.24.

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) last announced its earnings results on Friday, January 31st. The company reported $0.16 EPS for the quarter. Shionogi & Co., Ltd. had a return on equity of 12.02% and a net margin of 35.53%. On average, equities analysts predict that Shionogi & Co., Ltd. will post 0.66 earnings per share for the current fiscal year.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.